Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Merck Sharp & Dohme LLC
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Merck Sharp & Dohme LLC
Mural Oncology, Inc
AbbVie
pharmaand GmbH
Hoffmann-La Roche
ImmunoGen, Inc.
pharmaand GmbH
pharmaand GmbH
Pfizer
Hoffmann-La Roche
GOG Foundation
GOG Foundation
Novartis
ImmunoGen, Inc.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Janssen Research & Development, LLC
Alliance for Clinical Trials in Oncology
Genentech, Inc.
Alliance for Clinical Trials in Oncology
Mayo Clinic
INSYS Therapeutics Inc
Case Comprehensive Cancer Center
Eli Lilly and Company